Patents by Inventor Annette ZAMPONI

Annette ZAMPONI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COUGH SYRUP CONTAINING AMBROXOL HYDROCHLORIDE
    Publication number: 20170189330
    Abstract: The present invention relates to cough syrups containing ambroxol hydrochloride, characterised in that they are substantially free from glycerol, and their use for mucolytic treatment in acute and chronic diseases of the bronchi and/or lungs.
    Type: Application
    Filed: May 19, 2015
    Publication date: July 6, 2017
    Inventors: Bernd PLOHMANN, Katrin BUSZELLO, Uwe SCHEURING, Annette ZAMPONI
  • Aqueous composition comprising bromhexine
    Patent number: 9220693
    Abstract: The present invention relates to aqueous compositions containing bromhexine, the composition comprising an amount of sugar alcohols of less than 10 g based on 100 ml of the composition, and the use thereof for secretolytic therapy in acute and chronic bronchopulmonary disorders.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: December 29, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Uwe Scheuring, Bernd Plohmann, Annette Zamponi
  • AQUEOUS COMPOSITION COMPRISING BROMHEXINE
    Publication number: 20130267605
    Abstract: The present invention relates to aqueous compositions containing bromhexine, the composition comprising an amount of sugar alcohols of less than 10 g based on 100 ml of the composition, and the use thereof for secretolytic therapy in acute and chronic bronchopulmonary disorders.
    Type: Application
    Filed: July 7, 2011
    Publication date: October 10, 2013
    Inventors: Uwe Scheuring, Bernd Plohmann, Annette Zamponi
  • Use of selected CGRP antagonists for combating menopausal hot flushes
    Publication number: 20080176836
    Abstract: The invention relates to the use of selected CGRP antagonists, the physiologically acceptable salts thereof or the hydrates of the hydrates of the salts thereof for combating menopausal hot flushes.
    Type: Application
    Filed: July 9, 2007
    Publication date: July 24, 2008
    Inventors: Klaus Rudolf, Henri Doods, Stephan Georg Mueller, Annette Zamponi, Philipp Lustenberger, Kirsten Arndt, Gerhard Schaenzle, Dirk Stenkamp, Rolf-Stefan Brickl
  • Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine
    Publication number: 20080103134
    Abstract: The present invention relates to a process for the treatment or prevention of indications which are selected from among the group comprising headaches, migraine and cluster headaches, this process comprising the joint administration of a therapeutically effective amount of a selected CGRP antagonist (A), a physiologically acceptable salt thereof or a hydrate of the salt and a therapeutically effective amount of a second or third active anti-migraine medicament (B), particularly sumatriptan, zolmitriptan or dihydroergotamine or a physiologically acceptable salt thereof, and to the corresponding pharmaceutical compositions and the preparation thereof.
    Type: Application
    Filed: December 21, 2007
    Publication date: May 1, 2008
    Inventors: Klaus Rudolf, Henri Doods, Stephan Mueller, Annette Zamponi, Philipp Lustenberger, Kirsten Arndt, Gerhard Schaenzle, Dirk Stenkamp, Rolf-Stefan Brickl
  • Use of selected CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
    Publication number: 20070249592
    Abstract: The invention relates to a method of treatment or prevention of hot flushes in men who underwent castration, e.g. due to androgen ablation treatment in prostate cancer therapy, comprising administration of an effective amount of a selected CGRP antagonist to the patient, and to the use of said active compounds for the manufacture of a pharmaceutical composition intended to be used in this method.
    Type: Application
    Filed: July 9, 2007
    Publication date: October 25, 2007
    Inventors: Klaus Rudolf, Henri Doods, Stephan Mueller, Annette Zamponi, Philipp Lustenberger, Kirsten Arndt, Gerhard Schaenzle, Dirk Stenkamp, Rolf-Stefan Brickl
  • Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
    Publication number: 20060154921
    Abstract: The invention relates to a method of treatment or prevention of hot flushes in men who underwent castration, e.g. due to androgen ablation treatment in prostate cancer therapy, comprising administration of an effective amount of a selected CGRP antagonist to the patient, and to the use of said active compounds for the manufacture of a pharmaceutical composition intended to be used in this method.
    Type: Application
    Filed: December 13, 2005
    Publication date: July 13, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Klaus Rudolf, Henri Doods, Stephan Mueller, Annette Zamponi, Philipp Lustenberger, Kirsten Arndt, Gerhard Schaenzle, Dirk Stenkamp, Rolf-Stefan Brickl
  • Use of selected CGRP antagonists for combating menopausal hot flushes
    Publication number: 20060142274
    Abstract: The invention relates to the use of selected CGRP antagonists, the physiologically acceptable salts thereof or the hydrates of the hydrates of the salts thereof for combating menopausal hot flushes.
    Type: Application
    Filed: December 13, 2005
    Publication date: June 29, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Klaus Rudolf, Henri Doods, Stephan Mueller, Annette Zamponi, Philipp Lustenberger, Kirsten Arndt, Gerhard Schaenzle, Dirk Stenkamp, Rolf-Stefan Brickl
  • Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine
    Publication number: 20060142273
    Abstract: The present invention relates to a process for the treatment or prevention of indications which are selected from among the group comprising headaches, migraine and cluster headaches, this process comprising the joint administration of a therapeutically effective amount of a selected CGRP antagonist (A), a physiologically acceptable salt thereof or a hydrate of the salt and a therapeutically effective amount of a second or third active anti-migraine medicament (B), particularly sumatriptan, zolmitriptan or dihydroergotamine or a physiologically acceptable salt thereof, and to the corresponding pharmaceutical compositions and the preparation thereof.
    Type: Application
    Filed: December 16, 2005
    Publication date: June 29, 2006
    Applicant: Boehringer Ingelheim International Gmbh
    Inventors: Klaus RUDOLF, Henri DOODS, Stephan MUELLER, Annette ZAMPONI, Philipp LUSTENBERGER, Kirsten ARNDT, Gerhard SCHAENZLE, Dirk STENKAMP, Rolf-Stefan Brickl